Results 121 to 130 of about 30,962 (267)

Estimating the Calibrating Coefficient of the Framingham Score to Predict Risk of Coronary Heart Disease in the Taiwanese Population

, 2018
Hsing‐Yi Chang, Hsin‐Ling Fang, Ching-Yu Huang, Ling-Shen Hung, Kuo‐Liong Chien, Wen‐Harn Pan   +5 more
openalex   +1 more source

Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy‐confirmed co‐pathologies

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION Alzheimer's disease (AD) biomarkers are assessed on their ability to detect AD pathophysiology in vivo, with confirmation of AD neuropathology only at autopsy. METHODS Positron emission tomography (PET), plasma, and cognitive AD biomarkers were compared to AD neuropathology in Harvard Aging Brain Study participants (10 cognitively
Charles D. Chen, Cinthya Aguero, Alexandra Melloni, Brian C. Healy, Emma G. Thibault, Jessie Fanglu Fu, Michelle E. Farrell, Stephanie Schultz, Hyun‐Sik Yang, Jean‐Pierre Bellier, Jasmeer Chhatwal, Pia Kivisäkk Webb, Steven Arnold, Dana Penney, Randall Davis, Dorene Rentz, Teresa Gomez‐Isla, Reisa A. Sperling, Keith A. Johnson, Julie C. Price   +19 more
wiley   +1 more source

Association Between Carotid Atherosclerosis and Post‐Stroke Cognitive Impairment in Patients With Mild Ischemic Stroke: A Prospective Cohort Study

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Carotid ultrasound parameters, particularly Crouse score and severe carotid stenosis, are independently associated with post‐stroke cognitive impairment and may serve as simple, non‐invasive predictors for early risk stratification. ABSTRACT Background Post‐stroke cognitive impairment (PSCI) is a common yet frequently overlooked complication that ...
GuanHua Nie, ZhiHong Wei, Zhan Su, Haining Zhang   +3 more
wiley   +1 more source

Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients. [PDF]

Int J Gen Med, 2023
Adil SO, Uddin F, Musa KI, Khan A, Shakeel A, Shafique K, Islam MA.   +6 more
europepmc   +1 more source

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy

, 2013
Parthasarathi Roy
openalex   +1 more source

A Novel and Simple Score to Predict Embolic or Atherosclerotic Middle Cerebral Artery Occlusion Before Mechanical Thrombectomy: AHOC Score

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
This study developed and validated the novel AHOC score, a simple pre‐thrombectomy tool for predicting stroke etiology (embolism vs. intracranial atherosclerosis) in acute middle cerebral artery occlusion. This score integrates four key clinical/imaging variables—atrial fibrillation, hyperdense artery sign, stenosis/occlusion in other arteries, and ...
Hudie Zhang, Yingwen Su, Zubing Xu, Yunqing Chen, Rongwei Yang, Weiming Gan, Zhaojun Huang, Laisheng Cai, Chenying Zeng, Qin Huang, Jinchong Zhang, Keji Zou, Jingwei Huang, Pu Fang, Xiaobing Li, Yuhua Fan, Daojun Hong, Jing Lin   +17 more
wiley   +1 more source

High Concordance between D:A:Dr and the Framingham Risk Score in Brazilians Living with HIV. [PDF]

Viruses, 2023
Souza V, Valadares V, Dias T, Brites C.
europepmc   +1 more source

A Human Mass Balance and Metabolism Study of [14C]‐Ubrogepant in Healthy Male Adults

Clinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Ubrogepant is a calcitonin gene–related peptide receptor antagonist approved for the acute treatment of migraine with or without aura in adults. The mass balance and metabolism of ubrogepant was evaluated in six healthy male adults administered a single oral dose of [14C]‐ubrogepant 50 mg (∼200 µCi).
Ramesh R. Boinpally, Joshua Rowe, Pushpa Chandrasekar, Rebecca B. White, Eugene E. Marcantonio, Nicole Trainor, Yuexia Liang, Cheri Maciolek, James H. Small, Robert Houle, Michael J. Hafey, Huizhi Xie, Jocelyn Yabut, Christine Fandozzi   +13 more
wiley   +1 more source

Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Integrated framework for tirzepatide in HFpEF management. Through metabolic, haemodynamic, structural and anti‐inflammatory pathways, tirzepatide modifies the disease trajectory of HFpEF, leading to improvements in symptoms, functional capacity and reduction in HF events.
Hamza A. Abdul‐Hafez, Ameer Awashra, Sosana Bdir, Sarah Saife, Qasem Salah, Mohammed Barbarawi, Thabet Swaileh, Ahmed Emara, Mohamed S. Elgendy, Abdalhakim Shubietah   +9 more
wiley   +1 more source

Comparative Analysis of Waist-Height Ratio and Heart Rate Recovery for Predicting Coronary Heart Disease Risk Among Working Malaysian Women

International Journal of Women's Health
Chizheng Tang,1 Azmi Mohamed Nahar,2,3 Eng Wah Teo,1 Selina Khoo1 1Faculty of Sports & Exercise Science, Universiti Malaya, Kuala Lumpur, Malaysia; 2Department of Sport Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; 3Department
Tang C, Nahar AM, Teo EW, Khoo S
doaj